chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 01-SEP-2017, the patients were vaccinated with improperly stored VARIVAX (dose, frequency and route were unknown, lot # M049127, expiration date: 15-DEC-2018, lot # N010107, expiration date: 28-MAR-2019) for prophylaxis. Administered vaccine experienced the temperature excursion of -14 Celsius degree to -10 Celsius degree (-14.2 Celsius degree) for 6 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. No product quality complaint (PQC) was involved. This is one of several reports from the same reporter. All telephone attempts on 10-OCT-2017 to obtain follow up information have been unsuccessful. Follow up information has been received from an other reporter concerning a 13 month old patient. On 13-SEP-2017, the patient vaccinated with improperly stored VARIVAX (dose, frequency and route were unknown, lot # M049127, expiration date: 15-DEC-2018) for prophylaxis. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA002098: US-009507513-1709USA002186.
Information has been received from a physician concerning a 16 year old female who was vaccinated with Gardasil.  Concomitant therapy included tetanus toxoid in the same arm.  The patient developed a blister at the injection site.  The patient's sister also received the first dose of Gardasil and had the same adverse event (WAES #0801USA01424).  Subsequently, the patient recovered.  No further information was provided regarding this adverse experience.  This is one of several reports from the same source.  Additional information has been requested.
Developed Alopecia Areata. Twp large 5-6 cm. circular areas on top/side of head. Dermatologist injected  both areas and I am using minoxidil foam 5% daily since Jan. 10, 2018.  Too early for an outcome.
Adverse Event: Guest received his first dose of Pfizer vaccine 10 days prior to his 16th birthday.  Guest mother states that she did provide consent and was onsite at the time of the first dose of vaccination. Mother was onsite today when guest received his second dose and provided consent today as well. Treatment: None indicated .  Outcomes: Guest and his mother states that he had mild side effects that resolved within 24 hours.
Eye swelling, Ocular hyperemia, Pharyngolaryngeal pain. This non serious case was received on 11 March 2009 from VAERS (reference number 250295) via a search of the QSCAN database. A 55 year old female received FLUZONE SV '2005-'2006 lot number U1917AA) intramuscularly on 06 December 2005. ON 07 December 2005, the morning following the vaccination, the patient complained of a sore throat and red puffy eyes. She went to the office at 13:45 and requested BENADRYL. By the next morning, the patient's sore throat and red puffy eyes resolved after taking BENADRYL.
Information has been received from a physician concerning a male patient with a history of lymphoma who received a BMT in 2006, had a relapse in 2009 and responded completely to chemotherapy.  In May 2010 his primary care physician administered him a dose of VARIVAX (Oka/Merck) (lot # not reported).  In July 2010 the patient developed shingles on the T4 dermatome and was given a short course of acyclovir.  In September 2010 another episode on his face in VI distribution was reported.  Then October 2010 was the same distribution.  The patient was transferred to a hospital with pancytopenia, a bone marrow biopsy with granuloma, and skin biopsy showed Herpes viral inclusions with granulomas on his back lesions.  His CD4 on approximately 26-NOV-2010, just came back this morning at 53.  On 29-NOV-2010, the patient still had large lesions on his nose and forehead and back.  The facial lesions were present since mid October.  It was also reported that the skin biopsy was growing varicella ("and the reporter also noted that this was suspected varivax dissemination").  The patient had a hepatitis that they had biopsied and necrotizing granulomas on bone marrow.  The Infectious Disease faculty had started that patient on IV acyclovir and noted that the lesions were presumed to be crusted and resolving, but they were clearly active.  The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wild-type VZV strain or with the OKA/Merck vaccine strain.  Upon internal review pancytopenia was considered an other important medical event.  Additional information has been requested.
This spontaneous report was received from a Registered Nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In May 2016, the patients were vaccinated with the improperly stored doses of GARDASIL lot # K011325, expiration date on 30-APR-2017 and lot # K010215, expiration date on 05-MAY-2017 (dose was not reported). No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of 48 degrees Fahrenheit for 50 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same source. Additional information has been requested.
Client exposed to chicken pox on 10/19/03. Requested and received Varivax on 10/20/03. 11/12/03 to PMD for rash; red, quarter size swelling with white center on finger, 3 on lower back, 2-3 on thigh, 1 on leg, head itching, fatigue. BP elevated; no fever.
I63.9 - Stroke determined by clinical assessment I63.9 - Acute CVA (cerebrovascular accident) N17.9 - Acute kidney failure, unspecified R29.810 - Facial weakness
Labored breathing, temp fluctuating from 97-101, nauseous, awful joint pain everywhere, headache, conjunctivitis, throat sore, nodules in throat enormous...I?ve never ever ever had any adverse reactions to the annual flu shot.
9 hours after vaccine she developed a fever of 103. Then she developed diarrhea. By the next day she was vomiting, lethargic. She?s still running a fever, and has since developed hives and a rash. Fast respiration?s and heart rate. She was having a hard time keeping fluids down. Loss of appetite. She has a previous history of seizures after second dose of dtap. Her hives are painful, she is also very cranky when she?s normally a happy baby.
This spontaneous report was received from a physician referring to 13-month-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications or drug reactions or allergies was provided. On 07-JUN-2017, the patient was vaccinated with an improperly stored dose of VAQTA (lot # N005274 and expiration date 03-APR-2018; dose and route of administration were not reported) for prophylaxis. It was reported, that on several dates between 25-APR-2017 until 07-SEP-2017, the vaccine was exposed to various temperature excursions ranging from 32 degrees Fahrenheit (F) to 54F for the period of up to 70 hours at a time. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one case from several cases from the same reporter.; Sender's Comments: US-009507513-1709USA012768:
Began to feel dizzy and light headed.  Went to bathroom and for almost 10 minutes my body went into a full sweat.  I was soaking wet feeling either like I was going to faint or get sick.  I did neither.  After 10 minutes I was able to get up and dry myself off.  I then got a bottle of water and lied down for an hour.  I felt better after that.
I have been healthy prior to the vaccine.  Within 3 months of the vaccine I was diagnosed with Afib and have heart pains.  I  was directed to Cadiology, who referred me to Associates.  I have had a heart monitor study done followed by the implantation of a more permanent monitor and will be undergoing Ablation procedure on 10/18/2021. My heart rythm's have spiked and pressure on my heart is consistent.
Information has been received from a health professional concerning a female staff member who on 07-MAR-2008 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 658449/0989U). Subsequently, she developed cellulitis after receiving the vaccine. She was evaluated in a medical setting, and then admitted to the hospital where she was treated with intravenous antibiotics. She complained of generally not feeling well, which may have started prior to receiving pneumococcal 23v polysaccharide vaccine (Lot # 658449/0989U). On an unspecified date, she recovered. No product quality complaint involved. This is one of two reports from the same source. Additional information has been requested.
Chronic fatigue. Severe headaches unresponsive to medication. Numbness in face, left hand, graduating to numbness in entire left side Rapid weight loss/loss of strength (muscle mass). Obstructive/irritable bowels. Dizziness. Nausea. Localized swelling/pain immediately following the injection. Per follow up report-Pt still suffers from various ailments related to the reaction.  Limit of detection was completed and pt returned to AD for medical care.
C/o dizziness on 9/22/14, fatigue, headache, congestion, itchy eye. Tool 9/23/14 off b/c dizzienss and myalgia.
This spontaneous report as received from an unspecified (Control #54417) concerning a 67 year old female patient. Medical history and concurrent conditions were not reported. Patient had no known allergies. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose and route were not reported) Lot # J011651; Expiration date: 22-AUG-2015 (reported as 31-AUG-2014). In 2014, the patient had swelling of the arm, body aches, weak and fever. Patient did not had any trouble breathing and have no known allergies. Once patient was put on antibiotics, patient got better. This is one of 4 reports from the same reporter. Additional information has been requested.
A rash spontaneously began on Monday, November 29 around 3:30 pm.  It appeared in patches with embedded lines where it was scratched. The patches would disappear after approximately 30 minutes, then reappear in other locations. The skin is red with raised areas that look like lines or wheals, The locations where the rash appears include the face near the lip, chin, cheek, ear, chest (upper and middle front, side), breast area, abdomen, bikini line, shoulder, upper, middle and lower back, neck, armpit, wrist and upper arm, elbow, hand, thighs, knee, shin, ankle. Treatment included a 5-day course of prednisone 20 mg daily and Benadryl around-the-clock, as well as drinking lots of fluids, wearing soft clothes, and temperate baths with unscented bath products.
This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 60-year-old female patient received PREVNAR 13, via an unspecified route of administration in 2014 at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient had an allergy to the vaccine both the pneumococcal vaccine and the influenza vaccine on an unspecified date. The patient became extremely ill and was hospitalized for almost a week after the pneumococcal vaccine in 2014. The outcome of the events was unknown.
I tested positive for COVID-19 on 11/28/22. I had a fever, body aches, congestion, runny nose, scratchy throat, fatigue, elevated heartrate, and a cough. I contacted my doctor and was prescribed 5 days' worth of Paxlovid. I started feeling better, but it made me have a bad taste in my mouth.
Janssen COVID19 Vaccine EUA starting Tuesday morning, 3/30/2021 hands and feet are numb and tingling, like the nerves are exposed. went to emergency room 4/1/2021 -- could not reach a conclusion without further testing.  Told me to report this and call my doctor to arrange further testing to find out the cause -- CT scans, etc.
Had Covid after first shot; A spontaneous report was received from a reporter like a pharmacist concerning a 61 years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and reported events like had Covid after first shot/ Covid-19. The patient's medical history was not provided. Concomitant medications were not provided. On an unknown date, prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273(lot/batch: unknown) intramuscularly in the anatomical position for prophylaxis of COVID-19 infection. On an unknown date, the patient reported of experiencing Covid which was a mild case. Laboratory details were not provided. Treatment information was not provided. The outcome of the event of Covid was resolved. Action taken with mRNA-1273 in response to the events was unknown. At the time of this report, the outcome of the event was resolved.; Sender's Comments:  MOD21-025601: US-MODERNATX, INC.-MOD-2021-029217:
spent three days in sickbay; Initial information was received on 10-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves a patient (unknown demographics), who had spent three days in sickbay (illness), while the patient was treated with INFLUENZA VACCINE.  Medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient started taking INFLUENZA VACCINE produced by unknown manufacturer, (lot number expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious had spent three days in sickbay (illness), (unknown latency) following the INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  Outcome was unknown for the event at the time of reporting.  There will be no information available on the batch number for this case.
11-03-10 4:45 arms started aching & ears & face started itching, ears turned red - 2 Ibuprofen 5:10 BENADRYL 5:30 chest turned red, itching - all over (Afraid it would get worse 11-4-10) 6:30pm or so went to emergency - shot of DECADRON afternoon itching cheeks & nose turned red, bust was red took BENDARYL itching (my doctor said I shouldn't have any more flu shots - could get worse).
The excursion expiration date of 7 days thawed in the refrigerator was followed because of the Pfizer email approving the 7 days. The store policy was to follow  the expiration of 5 day
fever of 102.9, severe low back pain, and cramping of toes (toes would become contracted had to get up and walk in order to straighten them out)
Pt got his 2nd dose of Jynneos vaccine  on left forearm, same location as 1st dose. Both vaccines were given intradermal. By 10:00pm that night, he noticed water like substance coming out of skin where injection was placed and skin around injection site peeling. 11/3/22 patient states he noticed a few tiny blisters around injection site, itching sensation as well. No blisters noted on the rest of his body. Pt was encouraged contact his PCP for guidance. Pt admitted to nurse that he a nodule after his first vaccine dose in the same arm.
Following vax pt exp crying for hrs, very irritable, lt leg red, swollen, low fever per mom, local rxn; Given DPH, ice pack, no fever;
Large area bright red raised rash (L) arm at injection site, edema, pain. Fever 101.2.
none for the first day. Day of shot was fine. 2nd day about 2:30 -3 pm symptoms started while at work. My skin all over hurt for anything to touch it, even my clothes hurt my skin and no visible rash anywhere, had the RN check. 3rd same thing as 2nd day, arm swelling and red around injection site. Minor rash started around 12pm on 3rd day, periods of shortness of breath.  I am so far only 3 days in, the skin sensitivity all over is the worse I had to leave work. All reported to my nurse supervisor at work.
Patient received Tdap 6/3 and had severe local allergic reaction on (L) arm with probable cellulitis requiring admission.
positive test to the COVID-19 infection; This is a spontaneous report from a contactable Other HCP reporting for herself.   A 35-years-old female patient received bnt162b2 (BNT162B2; Lot# EL0140) vaccine  , via an unspecified route of administration in the left upper arm on 21Dec2020 at single dose for covid-19 immunisation .  The patient medical history and concomitant medications were not reported.  The patient resulted positive to the  test to the Covid-19 infection  on the same day she got the  vaccine 21Dec2020 with outcome of unknown.    The patient was wondering if her symptoms could worsened and if she could receive the second shot as scheduled.
Went to mall p/immun fever inc pt became unconscious-CPR done by nurse passing in mall was admitted to hosp;
Provider ordered Zostavax 0.65mL. RN gave patient 0.1mL of Zostavax since RN noted a bubble near injection site with redness. RN stopped injection and there was 0.5mL of Zostaax left in the syringe. RN informed provider and provider determined it was an allergic reaction. Provider ordered 25mg of Benadryl by mouth. Patient was observed for 20minutes before provider said he can go.
A healthcare professional reported that a pt received an injection of TD Adsorbed, Purogenated on 4/27/00 and subsequently developed injection site swelling described as the "size of a half dollar". This is 1 of 2 pts from this facility who developed injection site swelling following receipt of this vaccine, lot 465319.
EE received Covid-19 Moderna vaccine on 12/29/20 at 5:10 p.m. at Covid vaccination site. 12/30/20 at 3:00 a.m.EE had pain in left side, hip and leg waking EE up from sleep . Lesions times two, one on hip and one on posterior upper leg. MD insructed EE to double Vitamin C orally and to place Bacitracin on the two lesions, which at first appeared to contain bloody drainage. Lesions are now dry. VAERS document completed.
This case was considered medically important (OMIC). Information regarding Hib-Titer vaccine was received from a consumer, the mother, of a male patient who received a dose on an unspecified date. The patient also received on unspecified dates, a second dose of Hepatitis B vaccine, a third dose of Diphtheria/Tetanus Toxoids/Acellular Pertussis and a dose of Haemophilus B Conjugate Vaccine. The reporter indicated her son has autism. Relevant medical history was not provided. Indication for Hib-Titer vaccine was immunization. Product was administered on an unspecified date. Dose regimen was 1 dose. Additional suspect medication included Hepatitis B vaccine, Diphtheria/Tetanus Toxoids/Acellular Pertussis vaccine, and Haemophilus B Conjugate vaccine. Concomitant medications were not reported. On an unspecified date, the patient received a dose of Hib-Titer. The reporter stated her son has autism. The date of the event was unspecified. The patient's outcome is unknown. Product Quality has confirmed that Hib-Titer vaccine, lot number P1156AB, is not a valid product lot number. The reporter chose not to give any further details. Follow up is being conducted. No additional information was available at the time of this report.
bad headaches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced HEADACHE (bad headaches). At the time of the report, HEADACHE (bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
I started feeling out of sorts and coughing on 1/30/2023. On 1/31/2023, my cough deepened, but it wasn't productive. I also had a headache, but no fever or chills. At this point, I did a home antigen test and got a negative result. On 2/1/2023, I still had a deep cough, but it wasn't severe. I also had a slight temperature of maybe 100.0 or 100.2. I felt crummy, so I just curled up with a blanket. On 2/2/2023, I had had chills the previous night, so I took another home antigen test and got a positive result. I called my doctor's office and informed them of my situation, and they prescribed PAXLOVID, which I began taking late that afternoon. On 2/3/2023, I could tell the PAXLOVID was working, because my cough wasn't as deep, and my symptoms weren't any worse than before. I was also less hoarse, but I still felt sick and fatigued. I took another test on 2/12/2023 and got a negative result. I have more energy, but I don't have much endurance or feel like I'm running on all six cylinders. I have resumed some of my exercises, but I also make it a point to take it easy.
Pt vaccinated with DTP/OPV/HIB had persistant crying x 48 hrs, failure to eat or sleep.  Problem corrected with time no medications or studies.
there is a knot there; pain from my neck all the way down to my hand; really painful to touch; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOMFORT (there is a knot there), NECK PAIN (pain from my neck all the way down to my hand), PAIN (really painful to touch) and INJECTION SITE PAIN (pain at the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Sep-2021, the patient experienced INJECTION SITE DISCOMFORT (there is a knot there), NECK PAIN (pain from my neck all the way down to my hand), PAIN (really painful to touch) and INJECTION SITE PAIN (pain at the injection site). At the time of the report, INJECTION SITE DISCOMFORT (there is a knot there), NECK PAIN (pain from my neck all the way down to my hand), PAIN (really painful to touch) and INJECTION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment medication were reported.
CANNOT MOVE; This spontaneous report received from a patient via social media via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient experienced cannot move. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cannot move was not reported. This report was non-serious.
headache, chills, hives, itching/burning skin, nerve pain, fever (102.9) swelling of facial area, hands, fatigue, overall body pain, neck and back area pain, back of head pain